STAMFORD, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Medifast, Inc. (NYSE: MED) (“Medifast” or the “Company”) on behalf of the Company’s investors.
The investigation seeks to determine whether Medifast’s board of directors (the “Board”) has violated its fiduciary duty by instituting measures intended to interfere with the ability of Medifast stockholders to elect directors of their choosing.
Medifast stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing ac@abbottlawyer.com or visiting our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.
CONTACT:
Abbott Cooper PLLC
Abbott Cooper
(475) 333-0674
www.abbottlawyer.com
Attorney advertising. Prior results do not guarantee a similar outcome.
- TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - June 7, 2025
- Tulip Real Estate Acquires Premier London Hilton Property in £30 Million Deal from Lone Star - June 7, 2025
- Goldstein Patent Law Publishes Insights on How to Patent an Idea - June 7, 2025
